Clinical Study

A Phase 2/3, Multi-Center, Open-Label, Randomized Study Of Weekly Nab?- Paclitaxel In Combination With Gemcitabine Or Carboplatin, Compared To Gemcita

Posted Date: May 15, 2019

  • Investigator: Mahmoud Charif
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to see if nab-paclitaxel plus chemotherapy is more effective than one of the existing treatments for triple-negative metastatic breast cancer. The study has two different portions. The first portion will decide which chemotherapy will be used in combination with nab-pac

Criteria:

To Be Eligible For The Study You Must Have Been Diagnosed With Metastatic Breast Cancer

Keywords:

Abi-007-Mbc-001, Breast, Her2 Negative, Metastatic, Cancer

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.